AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea · Delayed Price · Currency is KRW 8,470.00
+150.00 (1.80%)
Apr 30, 2026, 3:30 PM KST
AptaBio Therapeutics Market Cap
AptaBio Therapeutics has a market cap or net worth of 237.95 billion as of April 30, 2026. Its market cap has increased by 23.63% in one year.
Market Cap
237.95B
Enterprise Value
225.18B
Revenue
3.70B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,470.00
Market Cap Chart
Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 237.95B, a decrease of -43.79%. That is a compound annual growth rate of -8.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 233.74B | -7.00% |
| Dec 30, 2025 | 251.34B | 46.78% |
| Dec 30, 2024 | 171.23B | -15.15% |
| Dec 28, 2023 | 201.80B | -15.02% |
| Dec 29, 2022 | 237.48B | -71.24% |
| Dec 30, 2021 | 825.71B | 46.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CMG Pharmaceutical | 264.64B |
| HLB Pharmaceutical | 248.41B |
| Hyundai Pharmaceutical | 243.29B |
| Boditech Med | 241.90B |
| Chong Kun Dang Holdings | 238.98B |
| Samjin Pharmaceuticals | 234.74B |
| Daewon Pharmaceutical | 232.98B |
| Suheung | 221.50B |